Compugen Net Worth

Compugen Net Worth Breakdown

  CGEN
The net worth of Compugen is the difference between its total assets and liabilities. Compugen's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Compugen's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Compugen's net worth can be used as a measure of its financial health and stability which can help investors to decide if Compugen is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Compugen stock.

Compugen Net Worth Analysis

Compugen's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Compugen's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Compugen's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Compugen's net worth analysis. One common approach is to calculate Compugen's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Compugen's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Compugen's net worth. This approach calculates the present value of Compugen's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Compugen's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Compugen's net worth. This involves comparing Compugen's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Compugen's net worth relative to its peers.

Enterprise Value

144.93 Million

To determine if Compugen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Compugen's net worth research are outlined below:
Compugen may become a speculative penny stock
Compugen had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 27.86 M. Net Loss for the year was (14.23 M) with profit before overhead, payroll, taxes, and interest of 19.36 M.
Compugen has a strong financial position based on the latest SEC filings
Latest headline from news.google.com: Is Compugen Ltd. a good long term investment - Triple-digit wealth increases - Jammu Links News
Compugen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Compugen. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Compugen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
26th of February 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Follow Compugen's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 144.01 M.

Market Cap

164.4 Million

Project Compugen's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.12)(0.13)
Return On Capital Employed(0.16)(0.16)
Return On Assets(0.12)(0.13)
Return On Equity(0.26)(0.27)
The company has Profit Margin (PM) of (0.51) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (3.68) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $3.68.
When accessing Compugen's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Compugen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Compugen's profitability and make more informed investment decisions.

Evaluate Compugen's management efficiency

Compugen has return on total asset (ROA) of (0.0807) % which means that it has lost $0.0807 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2422) %, meaning that it created substantial loss on money invested by shareholders. Compugen's management efficiency ratios could be used to measure how well Compugen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of July 2025, Return On Tangible Assets is likely to drop to -0.13. In addition to that, Return On Capital Employed is likely to drop to -0.16. At this time, Compugen's Non Current Assets Total are very stable compared to the past year. As of the 19th of July 2025, Other Assets is likely to grow to about 5.7 M, while Total Assets are likely to drop about 72.9 M.
Last ReportedProjected for Next Year
Book Value Per Share 0.61  0.58 
Tangible Book Value Per Share 0.61  0.58 
Enterprise Value Over EBITDA(8.45)(8.87)
Price Book Value Ratio 2.49  3.62 
Enterprise Value Multiple(8.45)(8.87)
Price Fair Value 2.49  3.62 
Enterprise Value109.5 M144.9 M
Compugen benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Enterprise Value Revenue
1.9085
Revenue
27.6 M
Quarterly Revenue Growth
(0.11)
Revenue Per Share
0.306
Return On Equity
(0.24)
Compugen time-series forecasting models is one of many Compugen's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Compugen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Compugen Earnings per Share Projection vs Actual

Compugen Corporate Management

Zurit LevineVP of Research and DiscoveryProfile
Alberto SessaChief OfficerProfile
Rivka SchwartzVice DiscoveryProfile
Henry MDSenior OfficerProfile
Eran OphirChief OfficerProfile
Michelle MDChief OfficerProfile
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.16)
Revenue Per Share
0.306
Quarterly Revenue Growth
(0.11)
Return On Assets
(0.08)
Return On Equity
(0.24)
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.